Durvalumab vs Tamoxifen

Durvalumab vs Tamoxifen: Overview

This comparison examines the pharmacological differences between Durvalumab and Tamoxifen.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Tamoxifen: Selective estrogen receptor modulator (SERM).

Pharmacokinetics

Half-life: Durvalumab — 17 days; Tamoxifen — 5-7 days.

Chemical Properties

Molecular Formula: Tamoxifen — C26H29NO.

Molecular Weight: Tamoxifen — 371.5150 g/mol.

Type: Durvalumab — Antibody; Tamoxifen — Small molecule.